Jeselsohn, Rinath
Buchwalter, Gilles
De Angelis, Carmine
Brown, Myles
Schiff, Rachel
Article History
First Online: 30 June 2015
Competing interests
: M.B. has received a commercial research grant and is a consultant/advisory board member for Novartis Pharmaceuticals. R.S. has received research funding from AstraZeneca and GlaxoSmithKline. The other authors declare no competing interests.